Medicine

Emerging Trends at the Intersection of AI & Marketing

admin March 21, 2024

In this Pharmaceutical Executive video interview, Kaveh Vahdat, Founder and President of RiseOpp, talks about what’s coming marketing with the use of AI.

LEAVE A RESPONSE Cancel reply

admin

View all posts

Medicine

Pharmaceutical Marketing Challenges & Trends to Expect on 2025: According to KOLs

admin December 15, 2024

Medicine

FDA Approves Verona’s Ohtuvayre for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease

admin June 29, 2024

Medicine

FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes

admin February 18, 2025

Medicine

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Breyanzi for Relapsed or Refractory CLL, SLL

admin March 16, 2024

Kwarlay.com

Kwarlay.com

Emerging Trends at the Intersection of AI & Marketing

LEAVE A RESPONSE Cancel reply

admin

Pharmaceutical Marketing Challenges & Trends to Expect on 2025: According to KOLs

FDA Approves Verona’s Ohtuvayre for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease

FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Breyanzi for Relapsed or Refractory CLL, SLL

Recent Posts

Archives

Categories

Emerging Trends at the Intersection of AI & Marketing

LEAVE A RESPONSE Cancel reply

admin

You Might Also Like

Pharmaceutical Marketing Challenges & Trends to Expect on 2025: According to KOLs

FDA Approves Verona’s Ohtuvayre for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease

FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Breyanzi for Relapsed or Refractory CLL, SLL

Recent Posts

Archives

Categories